11 Jul 2016 11:46
Immunodiagnostic Systems Holdings plc
Director Dealing
11 July 2016
Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets, was advised on 9 July that Peter Kaspar, Non-Executive Director, acquired 4,100 ordinary shares of 2p each ("Ordinary Shares") in the Company at an average price of €1.657 per Ordinary Share. At an average foreign exchange rate of €1.17 per £ this equates to a purchase price of £1.42 per ordinary share. The share purchases occurred on 7 and 8 July.
Following these purchases, Dr Kaspar is interested in 15,100 Ordinary Shares, 0.05% of the issued share capital of the Company.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Patricio Lacalle, Chief Executive Officer | |
Paul Martin, Group Finance Director | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Oliver Jackson |